Loading clinical trials...
Loading clinical trials...
Expanded Access of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD
Conditions
Interventions
remestemcel-L
Locations
27
United States
Phoenix Children's Hospital
Phoenix, Arizona, United States
Children's Hospital of Orange County
Orange, California, United States
UCSF
San Francisco, California, United States
Children's National
Washington D.C., District of Columbia, United States
Nemours Children's Clinic
Jacksonville, Florida, United States
University of Miami
Miami, Florida, United States
Last Updated
March 9, 2020
NCT06008808
NCT00106925
NCT07070674
NCT00001529
NCT06910969
NCT06660355
Lead Sponsor
Mesoblast, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions